Clinical Study New Gel for Xerostomia

2019-12-09 00:56:24 | BioPortfolio


At present, there is no single consensus protocol for the treatment of oral dryness, although the main objective is to improve the quality of life of patients. Current therapy for the control of xerostomia is based on the following measures:

1. General measures ; review and control of drugs,hydration and dietary advice:

The main recommendations are found in the following scheme.

2. Saliva stimulants( Topics and sistemic )The option of using chewing stimuli by chewing gum with non-cariogenic sweeteners helps to improve symptoms. The investigators can also use gustatory stimuli, such as citric acid that is a potent stimulator of salivary secretion.

Among the most commonly used pharmacological agents are: pilocarpine, bethanecol, civemiline

3. Saliva substitutes or artificial saliva. Saliva substitutes can provide a moisture retention layer in the oral mucosa and can be administered by liquids, spray, pills or gels. Topical treatments have few adverse effects and improve the quality of life of patients with xerostomia; In addition, they maintain oral health.


Randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and tolerability in patients with a non-commercialized gel and property of the promoter to treat xerostomia.

Study Design




gel xerostomia, gel placebo


Lopez-Jornet Pia
N/A = Not Applicable




Universidad de Murcia

Results (where available)

View Results


Published on BioPortfolio: 2019-12-09T00:56:24-0500

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

Stemcells for Radiation Induced Xerostomia

The current study aims to assess the safety and feasibility of the injection of autologous adipost tissue derived MSCs on radiation-induced salivary gland hypofunction and xerostomia in he...

OGT Spray in the Management of Xerostomia in the Elderly

The primary objective of the trial is to evaluate the efficacy, safety and clinical acceptability of OGT ormucosal spray in the relief of symptoms and signs of xerostomia in comparison wit...

Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation

The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.

Topical Management of Xerostomia With Dry Mouth Products

Objectives: To assess the effects of topical dry mouth products (toothpaste and mouthwash) containing olive oil, parsley oil, provitamin B5, allantoin, betaine and xylitol in Primary Sjög...

Effect of Pilocarpine in Patients With Xerostomia

The purpose of this study is to evaluate the effectiveness of a spray the basis of pilocarpine on salivary flow of patients with xerostomia, by radiation therapy, and primary Sjögren's Sy...

PubMed Articles [818 Associated PubMed Articles listed on BioPortfolio]

Validating the Xerostomia Inventory in a radiation-induced xerostomia population in German language.

Though xerostomia is a frequent oral symptom, there is no validated disease-specific questionnaire in German. The purpose of this study was to translate and validate versions of the Xerostomia Invento...

Degrees of xerostomia? A Rasch analysis of the Xerostomia Inventory.

The global demographic changes resulting in an ageing population require attention on xerostomia, as its prevalence appears to increase with age. The Xerostomia Inventory (XI) is a 11-item instrument ...

A randomized phase III trial for alleviating radiation-induced xerostomia with chewing gum.

Xerostomia is frequently reported after radiotherapy (RT) for head and neck cancer (HNC). The aim of this study was to reduce symptoms of radiation-induced xerostomia in HNC survivors, in which the ex...

Buccal adhesive chitosan conjugate comprising pilocarpine for xerostomia.

Xerostomia is caused by different factors such as side effects of medication, radiotherapy by head and neck cancer as well as Sjögren syndrome.

A deep learning model for predicting xerostomia due to radiotherapy for head-and-neck squamous cell carcinoma in the RTOG 0522 clinical trial.

Xerostomia commonly occurs in patients who undergo head-and-neck radiotherapy and can seriously affect patients' quality of life. In this study, we developed a xerostomia prediction model with radiati...

Medical and Biotech [MESH] Definitions

Decreased salivary flow.

A solution used for irrigating the mouth in xerostomia and as a substitute for saliva.

Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.

Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.

More From BioPortfolio on "Clinical Study New Gel for Xerostomia"

Quick Search

Searches Linking to this Trial